CD8A and COVID-19: discovered highly activated and highly cytotoxic CD16+ T cells among the CD4+ and CD8+ T cell compartments which were more abundant in severe COVID-19 as compared to mild disease or healthy controls and had the ability to elicit antibody-dependent cellular cytotoxicity (ADCC) (56).